Retrospective Study
Copyright ©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1127-1139
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1127
Figure 1
Figure 1 Selection of patient cohorts. 1In total, 135 patients had only one outpatient alterations in plasma protein metabolism (APPM) diagnosis and therefore did not meet these criteria; 2In total, 42 patients with fibrosis in the APPM cohort progressed to cirrhosis during follow-up; and 3In total, 280 patients with fibrosis in the control cohort progressed to cirrhosis during follow-up. ICD-10-GM: German Modification of the International Classification of Diseases-10th Revision.
Figure 2
Figure 2 Disease progression events. Disease progression events that occurred after the index date until the end of the study. APPM: Alterations in plasma protein metabolism.
Figure 3
Figure 3 Event-free survival for disease progression events in patients with cirrhosis with and without alterations in plasma protein metabolism. A: Ascites; B: Hepatic failure; C: Esophageal and gastric varices; D: Hepatic encephalopathy. APPM: Alterations in plasma protein metabolism; CI: Confidence interval; NR: Not reached.
Figure 4
Figure 4 Survival in patients with fibrosis and cirrhosis. A: Fibrosis; B: Cirrhosis. APPM: Alterations in plasma protein metabolism; CI: Confidence interval; NR: Not reached.